These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals. Niederhäuser S, Bruegger D, Zahno ML, Vogt HR, Peterhans E, Zanoni R, Bertoni G. Vaccine; 2008 Dec 09; 26(52):6749-53. PubMed ID: 18955098 [Abstract] [Full Text] [Related]
5. [Humoral immune response as a laboratory criterion for evaluation of the effectiveness of rabies vaccines]. Seroka D, Wysokińska T. Med Dosw Mikrobiol; 1982 Dec 09; 34(1-2):61-71. PubMed ID: 7144329 [No Abstract] [Full Text] [Related]
6. A poxvirus of primates. II. Immunology. Nicholas AH. J Natl Cancer Inst; 1970 Nov 09; 45(5):907-14. PubMed ID: 18605416 [Abstract] [Full Text] [Related]
7. A novel double-antigen sandwich enzyme-linked immunosorbent assay for Measurement of Antibodies against rabies virus. Yang LM, Zhao LZ, Hu RL, Shi ZS, Liu WJ. Clin Vaccine Immunol; 2006 Aug 09; 13(8):966-8. PubMed ID: 16893999 [Abstract] [Full Text] [Related]
8. Immunoglobulin idiotypes: analysis of viral antigen-antibody systems. Kennedy RC, Dreesman GR. Prog Med Virol; 1985 Aug 09; 31():168-82. PubMed ID: 2578680 [No Abstract] [Full Text] [Related]
9. Characterization of brain-associated rabies neutralizing substance. Gough PM, Dierks RE, Russell RM, Archer BG. J Infect Dis; 1974 Apr 09; 129(4):456-60. PubMed ID: 4206247 [No Abstract] [Full Text] [Related]
10. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs. Zhang S, Liu Y, Zhang F, Hu R. Vaccine; 2009 Mar 26; 27(15):2108-13. PubMed ID: 19356613 [Abstract] [Full Text] [Related]
11. Mechanisms of rabies virus neutralization. Flamand A, Raux H, Gaudin Y, Ruigrok RW. Virology; 1993 May 26; 194(1):302-13. PubMed ID: 7683158 [Abstract] [Full Text] [Related]
12. Complement fixing antigen in rabies. VII. Its application in sero-survey of vaccinated subjects. Rai Chowdhuri AN, Bhardwaj M, Sivaraman CA. J Commun Dis; 1981 Sep 26; 13(3):172-80. PubMed ID: 7343602 [No Abstract] [Full Text] [Related]
13. Development and evaluation of a rapid neutralizing antibody test for rabies. Shiota S, Mannen K, Matsumoto T, Yamada K, Yasui T, Takayama K, Kobayashi Y, Khawplod P, Gotoh K, Ahmed K, Iha H, Nishizono A. J Virol Methods; 2009 Oct 26; 161(1):58-62. PubMed ID: 19481115 [Abstract] [Full Text] [Related]
14. Antigenic properties of rabies virus components. Wiktor TJ, György E, Schlumberger D, Sokol F, Koprowski H. J Immunol; 1973 Jan 26; 110(1):269-76. PubMed ID: 4568184 [No Abstract] [Full Text] [Related]
15. Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology. Zhao XL, Yin J, Chen WQ, Jiang M, Yang G, Yang ZH. Microbiol Immunol; 2008 Feb 26; 52(2):89-93. PubMed ID: 18380806 [Abstract] [Full Text] [Related]
16. Revisiting rabies virus neutralizing antibodies through infecting BALB/c mice with live rabies virus. Qin Y, Smith TG, Jackson F, Gallardo-Romero NF, Morgan CN, Olson V, Hutson CL, Wu X. Virus Res; 2018 Mar 15; 248():39-43. PubMed ID: 29471052 [Abstract] [Full Text] [Related]